论文部分内容阅读
日前,中国医药集团旗下中国生物技术股股份有限公司已经启动H7N9疫苗研发关键技术及产品研发专项工作。2013年4月3日,国药中生联合中国疾病预防控制中心病病毒病预防控制所国家流感中心、中国食品药品检定研究院的有关专家,就如何开展疫苗研制工作组织召开了“人感染H7N9型禽流感病毒疫苗研发关键技术及产品研发”专题研讨会,对人用H7N9禽流感疫苗研制的重要环节,
Recently, China National Biotechnology Co., Ltd., a unit of China National Pharmaceutical Group, has started the key research and development of H7N9 vaccine and product development. On April 3, 2013, Sinopharm Health joined forces with the National Influenza Center of Disease Control and Prevention of Disease Control and Prevention and the experts of China National Institute of Food and Drug Control on how to carry out vaccine research and organized “Human Infection H7N9 Type avian influenza virus vaccine research and development of key technologies and product development ”Symposium on human H7N9 bird flu vaccine developed an important part,